Autonomic Effects on the QT Interval

Annals of Noninvasive Electrocardiology

Volumn 1, Issue 1, 1996, Pages 44-53

  Ahmed, Mizra W ^a   Kadish, Alan H ^a   Goldberger, Jeffrey J ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Adrenergic blockade; Parasympathetic blockade; Parasympathetic stimulation; Phenylephrine; Sympathetic stimulation; Tilt

Indexed keywords

EID: 0002449001     PISSN: 1082720X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-474X.1996.tb00261.x     Document Type: Article

References (37)

1. Dekker J, Schouten E, Klootwijk P, et al. Association between QT interval and coronary heart disease in middle-aged and elderly men: The Zutphen study. Circulation 1994; 90:779-785.
2. Algra A, Tijssen J, Roelandt I, et al. QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation 1991; 83:1888-1894.
3. Schouten E, Dekker J, Meppelink P, et al. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 1991; 84:1516-1523.
4. Schwartz P, Wolf S. QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 1978; 57:1074-1077.
5. Bigger J, Fleiss J, Steinman R, et al. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992; 85:164-171.
6. Kleiger RE, Miller P, Bigger JT, et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59:256-262.
7. Conn J, Levine T, Olivari M, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311:819-823.
8. Cryer PE. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med 1980; 303:436-444.
9. Cohen G, Holland B, Sha J, et al. Plasma concentrations of epinephrine and norepinephrine during intravenous infusions in man. J Clin Invest 1959; 38:1935-1941.
10. Browne K, Zipes D, Heger J, et al. Influence of the autonomic nervous system on the Q-T interval in man. Am J Cardiol 1982; 50:1099-1103.
11. Ahnve S, Vallin H. Influence of heart rate and inhibition of autonomic tone on the QT interval. Circulation 1982; 65:435-439.
12. Browne K, Prystowski E, Heger J, et al. Modulation of the Q-T interval by the autonomic nervous system. PACE 1983; 6:1050-1055.
13. Milne J, Camm A, Ward D, et al. Effect of intravenous propranolol on QT interval. A new method of assessment. Br Heart J 1980; 43:1-6.
14. Sarma J, Venkatraman K, Samant D, et al. Effect of propranolol on the QT intervals of normal individuals during exercise: A new method for studying interventions. Br Heart J 1988; 60:434-439.
15. Tonkin A, Tornos P, Heddle W, et al. Autonomic effects on the human cardiac conduction system. Evaluation by intracardiac electrocardiography and programmed stimulation techniques. Br Heart J 1980; 44:168-174.
16. Ehlert F, Goldberger J, Rosenthal J, et al. Relation between QT and RR intervals during exercise testing in atrial fibrillation. Am J Cardiol 1992; 70:332-338.
17. Dickhuth H, Bluemner E, Auchschwelk W, et al. The relationship between heart rate and QT interval during atrial stimulation. PACE 1991; 14:793-799.
18. Arnold L, Page J, Attwell D, et al. The dependence on heart rate of the human ventricular action potential duration. Cardiovasc Res 1982; 16:547-551.
19. Seed W, Noble M, Oldershaw P, et al. Relation of human cardiac action potential duration to the interval between beats: Implications for the validity of rate corrected QT interval (QTc). Br Heart J 1987; 57:32-37.
20. Seides S, Josephson M, Batsford W, et al. The electrophysiology of propranolol in man. Am Heart J 1974; 88(6):733-741.
21. Zipes D, Miyazala T. The autonomic nervous system and the heart: Basis for understanding interactions and effects on arrhythmia development. In DP Zipes, J Jalüe (eds.): Cardiac Electrophysiology: From Cell to Bedside. WB Saunders Co., Philadelphia, PA, 1990, pp. 312-330.
22. Chang M, Zipes D. Differential sensitivity of sinus node, atrioventricular node, atrium, and ventricle to propranolol. Am Heart J 1988; 116:371-378.
23. Ahmed M, Kadish A, Parker M, et al. Effect of physiologic and pharmacologic adrenergic stimulation on heart rate variability. J Am Coll Cardiol 1994; 24:1082-1090.
24. Goldberger J, Ahmed M, Parker M, et al. Assessment of effects of autonomic stimulation and blockade on the signal-averaged electrocardiogram. Circulation 1994; 89:1656-1664.
25. Jose AD, Taylor RR. Autonomic blockade by propranolol and atropine to study intrinsic myocardial function in man. J Clin Invest 1969; 48:2019-2031.
26. Pickering T, Gribbin B, Stage-Peterson E, et al. Effects of autonomic blockage on the baroreflex in man at rest and during exercise. Circ Res 1972; 30:177-185.
27. Clutter W, Bier D, Shah S, et al. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest 1980; 66:94-101.
28. Martinsson A, Lindvall K, Melcher A, et al. Beta-adrenergic receptor responsiveness to isoprenaline in humans: Concentration-effect, as compared with dose-effect evaluation and influence of autonomic reflexes. Br J Clin Pharmac 1989; 28:83-94.
29. Bazett H. An analysis of the time relations of electrocardiogram. Heart 1920; 7:353-370.
30. Fridericia L. Die systolendauer im elektrokardiogramm bei normalen Menschen und bei herzkranken. Acta Med Scand 1920; 53:489.
31. Karjalainen J, Vitasalo M, Manttari M, et al. Relation between QT intervals and heart rates from 40 to 120 beats/ min in rest electrocardiograms of men and a simple method to adjust QT interval values. J Am Coll Cardiol 1994; 23:1547-1553.
32. Sanna J, Sanna R, Bilitch M, et al. An exponential formula for heart rate dependence of QT interval during exercise and cardiac pacing in humans: Reevaluation of Bazen's formula. Am J Cardiol 1984; 54:103-108.
33. Duff H, Roden D, Brorson L, et al. Electrophysiologic actions of high plasma concentrations of propranolol in human subjects. J Am Coll Cardiol 1983; 2:1134-1140.
34. Cappato R, Alboni P, Pedroni P, et al. Sympathetic and vagal influences on rate-dependent changes of QT interval in healthy subjects. Am J Cardiol 1991; 68:1188-1193.
35. Echt D, Berte L, Clusin W, et al. Prolongation of the human cardiac monophasic action potential by sotalol. Am J Cardiol 1982; 50:1082-1086.
36. Kowey P, Verrier R, Lown B. Effect of alpha-adrenergic receptor stimulation on ventricular electrical properties in the normal canine heart. Am Heart J 1983; 105:366-371.
37. Staniforth D. The QT interval and cycle length: The influence of atropine, hyoscine and exercise. Br Heart J 1983; 16:615-621.